|
Status |
Public on Feb 08, 2024 |
Title |
PB02009_tumor_roi001_ImmuneCell |
Sample type |
protein |
|
|
Source name |
PB02009_tumor_roi001_ImmuneCell
|
Organism |
Homo sapiens |
Characteristics |
patient id: PB02009 tissue type: tumor region of interest (roi) number: roi001 segment type: immune cell enriched positive immuno-fluorescent morphology marker: CD45 radiographic objective response: stable disease (SD)
|
Treatment protocol |
Pre-treatment tumor and liver biopsy tissues were obtained from patients with unresectable hepatocellular carcinoma trated with bavituximab and pembrolizumab.
|
Growth protocol |
na
|
Extracted molecule |
protein |
Extraction protocol |
Refer to the NanoString Digital Spatial Profiling (DSP) GeoMx analysis manuals
|
Label |
fluorescent barcode
|
Label protocol |
Refer to the NanoString Digital Spatial Profiling (DSP) GeoMx analysis manuals
|
|
|
Hybridization protocol |
Refer to the NanoString Digital Spatial Profiling (DSP) GeoMx analysis manuals
|
Scan protocol |
Refer to the NanoString Digital Spatial Profiling (DSP) GeoMx analysis manuals
|
Description |
protein detected by antibody
|
Data processing |
Raw count data of antibody-captured protein copy numbers in each segment were normalized by scaling with geometric mean of the counts of the housekeeping proteins
|
|
|
Submission date |
Sep 01, 2023 |
Last update date |
Feb 08, 2024 |
Contact name |
Yujin Hoshida |
E-mail(s) |
Yujin.Hoshida@UTSouthwestern.edu
|
Organization name |
University of Texas Southwestern Medical Center
|
Street address |
5323 Harry Hines Blvd
|
City |
Dallas |
State/province |
TX |
ZIP/Postal code |
75390 |
Country |
USA |
|
|
Platform ID |
GPL33726 |
Series (1) |
GSE242154 |
Spatial immuno-oncology protein abundance profiles in hepatocellular carcinoma tissues from patients treated with bavituximab and pembrolizumab |
|